APA

Aguilar-Salinas C. A., Fanghänel-Salmón G., Meza E., Montes J., Gulías-Herrero A., Sánchez L., Monterrubio-Flores E. A., González-Valdez H. & Gómez Pérez F. J. (20010705). Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study. : Metabolism: clinical and experimental.

Chicago

Aguilar-Salinas C A, Fanghänel-Salmón G, Meza E, Montes J, Gulías-Herrero A, Sánchez L, Monterrubio-Flores E A, González-Valdez H and Gómez Pérez F J. 20010705. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study. : Metabolism: clinical and experimental.

Harvard

Aguilar-Salinas C. A., Fanghänel-Salmón G., Meza E., Montes J., Gulías-Herrero A., Sánchez L., Monterrubio-Flores E. A., González-Valdez H. and Gómez Pérez F. J. (20010705). Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study. : Metabolism: clinical and experimental.

MLA

Aguilar-Salinas C A, Fanghänel-Salmón G, Meza E, Montes J, Gulías-Herrero A, Sánchez L, Monterrubio-Flores E A, González-Valdez H and Gómez Pérez F J. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study. : Metabolism: clinical and experimental. 20010705.